VRCAVerrica Pharmaceuticals Inc.vs its industry peers
A metric-by-metric comparison of Verrica Pharmaceuticals Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRCA본 종목 | $79M#7 | — | 18.2x#12 | 2.2x#2 | 370.2%#2 | 76.6%#1 | -34.2%#2 | -415.6%#13 | -36.1%#2 | — | -9.7%#1 | — |
| FBIO | — | 0.9x#1 | — | — | 9.7%#4 | 76.2%#2 | -111.0%#3 | 22.5%#1 | — | — | — | — |
| MAIA | $82M#1 | — | 3.9x#7 | — | — | 3.7%#4 | — | -108.3%#7 | — | — | — | — |
| OSTX | $81M#2 | — | — | — | — | -223.7%#16 | — | — | — | — | — | — |
| TELO | $80M#3 | — | 15.8x#10 | — | — | 37.0%#3 | — | -206.9%#11 | — | — | — | — |
| LFVN | $79M#6 | 15.8x#3 | 2.4x#5 | 0.4x#1 | -20.1%#5 | -48.3%#12 | 3.3%#1 | 15.1%#2 | 28.2%#1 | 6#1 | — | 3.0%#1 |
| CTOR | $80M#4 | — | 2.0x#4 | — | — | -17.1%#8 | — | -61.3%#3 | — | — | — | — |
| ACET | $79M#5 | — | 0.7x#1 | — | — | 0.3%#7 | — | -97.2%#6 | — | — | -33.8%#2 | — |
| LNAI | $78M#8 | 1.1x#2 | — | 2390.9x#6 | -47.8%#6 | -101.3%#13 | -576678.5%#7 | — | — | 5#2 | — | — |
| LEXX | $78M#9 | — | 16.5x#11 | 110.6x#4 | 52.0%#3 | -105.4%#14 | -1683.0%#5 | -251.2%#12 | — | — | — | — |
| RNXT | $78M#10 | — | 8.7x#9 | 69.5x#3 | 2511.6%#1 | -26.7%#9 | -1114.0%#4 | -124.4%#9 | — | — | — | — |
| ACRV | $78M#11 | — | 0.9x#2 | — | — | 3.3%#5 | — | -89.9%#4 | — | — | — | — |
| GANX | $75M#12 | — | 6.6x#8 | 1360.4x#5 | -58.4%#7 | 1.2%#6 | -33908.5%#6 | -178.5%#10 | — | — | — | — |
| CING | $74M#13 | — | 3.1x#6 | — | — | -35.6%#11 | — | -95.7%#5 | — | — | — | — |
| SKYE | $73M#14 | — | — | — | — | -110.5%#15 | — | — | — | — | — | — |
| PMVP | $72M#15 | — | 1.0x#3 | — | — | -32.0%#10 | — | -108.7%#8 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice